These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 19252243)
21. [RANKL signal and osteoimmunology]. Nakashima T; Takayanagi H Clin Calcium; 2011 Aug; 21(8):1131-40. PubMed ID: 21814017 [TBL] [Abstract][Full Text] [Related]
22. IL-17 stimulates the proliferation and differentiation of human mesenchymal stem cells: implications for bone remodeling. Huang H; Kim HJ; Chang EJ; Lee ZH; Hwang SJ; Kim HM; Lee Y; Kim HH Cell Death Differ; 2009 Oct; 16(10):1332-43. PubMed ID: 19543237 [TBL] [Abstract][Full Text] [Related]
23. Erosive arthritis. Schett G Arthritis Res Ther; 2007; 9 Suppl 1(Suppl 1):S2. PubMed ID: 17634141 [TBL] [Abstract][Full Text] [Related]
24. Fetal BM-derived mesenchymal stem cells promote the expansion of human Th17 cells, but inhibit the production of Th1 cells. Guo Z; Zheng C; Chen Z; Gu D; Du W; Ge J; Han Z; Yang R Eur J Immunol; 2009 Oct; 39(10):2840-9. PubMed ID: 19637224 [TBL] [Abstract][Full Text] [Related]
25. TLR3 ligand polyinosinic:polycytidylic acid induces IL-17A and IL-21 synthesis in human Th cells. Holm CK; Petersen CC; Hvid M; Petersen L; Paludan SR; Deleuran B; Hokland M J Immunol; 2009 Oct; 183(7):4422-31. PubMed ID: 19748983 [TBL] [Abstract][Full Text] [Related]
26. Th17 cells and rheumatoid arthritis--from the standpoint of osteoclast differentiation--. Sato K Allergol Int; 2008 Jun; 57(2):109-14. PubMed ID: 18427163 [TBL] [Abstract][Full Text] [Related]
27. [Role of osteoclasts in bone destruction in rheumatoid arthritis]. Suzuki Y Nihon Rinsho Meneki Gakkai Kaishi; 2001 Jun; 24(3):87-97. PubMed ID: 16578961 [No Abstract] [Full Text] [Related]
28. [Prevention of joint destruction by osteoclast-targeting therapy in search of new tools, such as OPG or cathepsin K inhibitor]. Kadono Y; Tanaka S Clin Calcium; 2009 Mar; 19(3):387-93. PubMed ID: 19252249 [TBL] [Abstract][Full Text] [Related]
29. Regulation of osteoclast differentiation and function by interleukin-1. Nakamura I; Jimi E Vitam Horm; 2006; 74():357-70. PubMed ID: 17027523 [TBL] [Abstract][Full Text] [Related]
30. Receptor activator of nuclear factor-kappaB ligand-induced mouse osteoclast differentiation is associated with switching between NADPH oxidase homologues. Sasaki H; Yamamoto H; Tominaga K; Masuda K; Kawai T; Teshima-Kondo S; Matsuno K; Yabe-Nishimura C; Rokutan K Free Radic Biol Med; 2009 Jul; 47(2):189-99. PubMed ID: 19409483 [TBL] [Abstract][Full Text] [Related]
31. Impact of cytokines and T lymphocytes upon osteoclast differentiation and function. Gillespie MT Arthritis Res Ther; 2007; 9(2):103. PubMed ID: 17381830 [TBL] [Abstract][Full Text] [Related]
32. [Expectation for alleviation of joint destruction in rheumatoid arthritis by new molecular targeting pharmaceutics including anti-rankle antibody]. Nakamura T Clin Calcium; 2009 Mar; 19(3):381-6. PubMed ID: 19252248 [TBL] [Abstract][Full Text] [Related]
34. Osteoimmunology: crosstalk between the immune and bone systems. Nakashima T; Takayanagi H J Clin Immunol; 2009 Sep; 29(5):555-67. PubMed ID: 19585227 [TBL] [Abstract][Full Text] [Related]
35. [Mechanism of bone destruction in rheumatoid arthritis]. Takayanagi H Clin Calcium; 2003 Jun; 13(6):694-701. PubMed ID: 15775138 [TBL] [Abstract][Full Text] [Related]
36. [Mechanism of bone and cartilage damage in rheumatoid arthritis]. Komatsu N; Takayanagi H Clin Calcium; 2015 Dec; 25(12):1749-55. PubMed ID: 26608848 [TBL] [Abstract][Full Text] [Related]
37. Regulatory mechanism of NFATc1 in RANKL-induced osteoclast activation. Song I; Kim JH; Kim K; Jin HM; Youn BU; Kim N FEBS Lett; 2009 Jul; 583(14):2435-40. PubMed ID: 19576893 [TBL] [Abstract][Full Text] [Related]
39. [Osteoporosis in rheumatoid arthritis: role of osteoclast differentiation and cytokines]. Tanaka S Clin Calcium; 2001 May; 11(5):598-601. PubMed ID: 15775560 [TBL] [Abstract][Full Text] [Related]